Answers are grounded in this paper and cite their sources.
Summary. Benefit‐cost analysis is a type of policy analysis still in a developing stage, particularly with respect to investments in people. Policy analysts, policy makers, and other users concur this type of analysis cannot be a sufficient basis for public policy decisions. For health programs, it is an approach that can supplement medical and epidemiologic bases for public investment decisions. It is a useful tool where an understanding of health problems is deficient in some areas. This paper discusses some examples of the use of benefit‐cost analysis in planning disease prevention programs and the explicit consideration to the quality of life benefits associated with reduced disease.
No takes yet. Share an insight, caveat, or question.
Sencer et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: